These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells. Shorter RG; Huizenga KA; Spencer RJ; Guy SK Am J Dig Dis; 1972 Aug; 17(8):689-96. PubMed ID: 5046733 [No Abstract] [Full Text] [Related]
3. Properties of the inferferon-like virus inhibitor released during interaction of mouse sensitized lymphocytes with their target cells. Borecký L; Fuchsberger N; Zemla J; Lackovic V Eur J Immunol; 1971 Jun; 1(3):213-8. PubMed ID: 4331347 [No Abstract] [Full Text] [Related]
4. Release of macrophage migration inhibitory factor(s) from lymphocytes stimulated by streptococcal preparations. Seravalli E; Taranta A Cell Immunol; 1973 Jul; 8(1):40-54. PubMed ID: 4738315 [No Abstract] [Full Text] [Related]
5. Some properties of polyoma virus "T" and "tumour" antigens. Zembala M; Ptak W; Porwit-Bobr Z Z Immunitatsforsch Exp Klin Immunol; 1970; 141(1):27-36. PubMed ID: 4323568 [No Abstract] [Full Text] [Related]
6. Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Kolb WP; Granger GA Proc Natl Acad Sci U S A; 1968 Dec; 61(4):1250-5. PubMed ID: 5249808 [No Abstract] [Full Text] [Related]
7. An antiviral substance from Penicillium cyaneo-fulvum biourge. 3. Studies on the nature of the antiviral subtance. Syeklocha D; Cooke PM; Stevenson JW Can J Microbiol; 1967 Nov; 13(11):1481-8. PubMed ID: 6064041 [No Abstract] [Full Text] [Related]
8. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595 [TBL] [Abstract][Full Text] [Related]
9. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid. Oh SK; Moolten FL Eur J Immunol; 1981 Oct; 11(10):780-8. PubMed ID: 6273181 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Rolny P; Järnerot G; Möllby R Scand J Gastroenterol; 1983 Jan; 18(1):61-4. PubMed ID: 6144171 [TBL] [Abstract][Full Text] [Related]